Skip to content

13F-HR filed by Omega Fund Management, LLC

Omega Fund Management, LLC filed this 13F-HR for the quarter ended 2017-06-30, filed 2017-07-26, with 11 holding rows worth $160,240,000.

Accession
0000950123-17-006325
Filed
2017-07-26
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2017

A holdings report, 11 entries on the cover page, a total value of $160,240,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $160,239,000 with VALUE read as thousands by filing date, 13F file number 028-16844. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
PARATEK PHARMACEUTICALS INC699374302Equity2,600,410$62,670,000thousands by filing date
JUNO THERAPEUTICS INC48205A109COM1,229,512$36,750,000thousands by filing date
FIBROGEN INC31572Q808COM627,492$20,268,000thousands by filing date
NABRIVA THERAPEUTICS PLCG63637105SHS1,139,035$11,937,000thousands by filing date
JOUNCE THERAPEUTICS INC481116101COM579,650$8,132,000thousands by filing date
PIERIS PHARMACEUTICALS INC720795103COM1,367,253$6,918,000thousands by filing date
EGALET CORP28226B104COM2,889,926$6,849,000thousands by filing date
CIDARA THERAPEUTICS INC COM NEW171757107Stock444,965$3,337,000thousands by filing date
CYMABAY THERAPEUTICS INC23257D103COM301,477$1,737,000thousands by filing date
ESSA PHARMA INC29668H104COM1,696,969$933,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM223,457$708,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-17-006325this filing2017-07-26acceptance time not in the bulk data set